Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1989;80:254-260

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldman, L.
Right arrow Articles by Williams, L. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldman, L.
Right arrow Articles by Williams, L. W.

Circulation, Vol 80, 254-260, Copyright © 1989 by American Heart Association


ARTICLES

Relative impact of targeted versus populationwide cholesterol interventions on the incidence of coronary heart disease. Projections of the Coronary Heart Disease Policy Model

L Goldman, MC Weinstein and LW Williams
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115

We used the Coronary Heart Disease Policy Model, a state-transition computer simulation, to assess the absolute and relative effects of two different national cholesterol interventions: a targeted program to identify and treat all individuals with elevated serum cholesterol levels (greater than or equal to 250 mg/dl) versus a populationwide program to reduce everyone's serum cholesterol level. Based on the assumptions inherent in our model, which uses the Framingham Heart Study coefficients, we estimate the targeted program would reduce projected coronary heart disease absolute incidence by 8-10% in men ages 35-54 years and by 1-4% in men ages 55-74 years. Our model suggests that similar reductions in coronary heart disease incidence could be achieved by a 10 mg/dl populationwide reduction in serum cholesterol levels. In women, the targeted program would yield greater relative and absolute benefits and would be equivalent to a approximately 23 mg/dl populationwide reduction in serum cholesterol. We conclude that it would be inadvisable to rely solely on targeted cholesterol reduction programs to reduce national coronary heart disease.


This article has been cited by other articles:


Home page
JAMAHome page
K. A. Phillips, M. G. Shlipak, P. Coxson, P. A. Heidenreich, M. G. M. Hunink, P. A. Goldman, L. W. Williams, M. C. Weinstein, and L. Goldman
Health and Economic Benefits of Increased {beta}-Blocker Use Following Myocardial Infarction
JAMA, December 6, 2000; 284(21): 2748 - 2754.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
J. R. Beck and S. G. Pauker
Does DEALE-ing Stack the Deck?
Med Decis Making, October 1, 1999; 19(4): 503 - 504.
[PDF]


Home page
J Am Coll CardiolHome page
L. Goldman, P. Coxson, M. G. M. Hunink, P. A. Goldman, A. N. A. Tosteson, M. Mittleman, L. Williams, and M. C. Weinstein
The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines
J. Am. Coll. Cardiol., September 1, 1999; 34(3): 768 - 776.
[Abstract] [Full Text] [PDF]


Home page
Stat Methods Med ResHome page
A. L Hersh, W. C Black, and A. N. Tosteson
Estimating the population impact of an intervention: a decision-analytic approach
Statistical Methods in Medical Research, August 1, 1999; 8(4): 311 - 330.
[Abstract] [PDF]


Home page
CirculationHome page
A. N.A. Tosteson, M. C. Weinstein, M. G.M. Hunink, M. A. Mittleman, L. W. Williams, P. A. Goldman, and L. Goldman
Cost-Effectiveness of Populationwide Educational Approaches to Reduce Serum Cholesterol Levels
Circulation, January 7, 1997; 95(1): 24 - 30.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
S. A. Grover, K. Gray-Donald, L. Joseph, M. Abrahamowicz, and L. Coupal
Life Expectancy Following Dietary Modification or Smoking Cessation: Estimating the Benefits of a Prudent Lifestyle
Arch Intern Med, August 8, 1994; 154(15): 1697 - 1704.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
E. Y. Brown, C. M. Viscoli, and R. I. Horwitz
Preventive Health Strategies and the Policy Makers' Paradox
Ann Intern Med, April 1, 1992; 116(7): 593 - 597.
[Abstract] [PDF]


Home page
JAMAHome page
L. Goldman, M. C. Weinstein, P. A. Goldman, and L. W. Williams
Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart Disease
JAMA, March 6, 1991; 265(9): 1145 - 1151.
[Abstract] [PDF]